mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination

Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to inc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:npj vaccines Jg. 9; H. 1; S. 202 - 2
Hauptverfasser: Shaia, Jacqueline K., Shukla, Priya, Jampol, Lee, Singh, Rishi P.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 28.10.2024
Nature Publishing Group
Nature Portfolio
Schlagworte:
ISSN:2059-0105, 2059-0105
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.
AbstractList Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.
Abstract Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.
Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.
ArticleNumber 202
Author Jampol, Lee
Shaia, Jacqueline K.
Shukla, Priya
Singh, Rishi P.
Author_xml – sequence: 1
  givenname: Jacqueline K.
  surname: Shaia
  fullname: Shaia, Jacqueline K.
  organization: Case Western School of Medicine Department of Population and Quantitative Health Sciences, Center for Ophthalmic Bioinformatics Cleveland Clinic
– sequence: 2
  givenname: Priya
  surname: Shukla
  fullname: Shukla, Priya
  organization: Center for Ophthalmic Bioinformatics Cleveland Clinic, Cleveland Clinic Lerner College of Medicine
– sequence: 3
  givenname: Lee
  surname: Jampol
  fullname: Jampol, Lee
  organization: Department of Ophthalmology, Feinberg School of Medicine, Northwestern University
– sequence: 4
  givenname: Rishi P.
  surname: Singh
  fullname: Singh, Rishi P.
  email: SINGHR@ccf.org
  organization: Center for Ophthalmic Bioinformatics Cleveland Clinic, Cleveland Clinic Martin Hospitals
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39468063$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhiNUREvpH-CALHHhEhjHsWOfULXlY6WKlSro1XLsyTZLYi92dqv-e9zdUrYcOI0_nnlnxn5fFkc-eCyK1xTeU2DyQ6opr2kJVV0CKMlKeFacVMBVCRT40cH6uDhLaQUAtBGMN_CiOGaqFhIEOyn68erbOZktrucXJVVka6ztvZn64BMxEYkPEzEpBdubCR257acbcnW9IA63OIT1iH4iFSXO3GXeO0Ircov4M2-6CeOh3qvieWeGhGcP8bT48fnT99nX8nLxZT47vyxtraqpxJYxZ5wEBU3rGhQda7nAWjEwnZFWWes6MLIR2LAOABt0Nsc8WM1QCXZazPe6LpiVXsd-NPFOB9Pr3UGIS23i1NsBNe9aLlumjBKqrmopHTSSQkcNQ-ekzVof91rrTTvmOnnaaIYnok9vfH-jl2GrKeVUCc6zwrsHhRh-bTBNeuyTxWEwHsMmaUYryhWrKpXRt_-gq7CJPr_VjqpFAwwy9eawpcde_nxpBqo9YGNIKWL3iFDQ99bRe-vobB29s46-V2X7pJRhv8T4t_Z_sn4DJQDEGA
Cites_doi 10.1111/his.14134
10.1038/s41541-023-00661-7
10.1001/jamaophthalmol.2023.0925
10.1016/j.survophthal.2021.04.001
10.1001/jamaophthalmol.2023.0610
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID C6C
AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
88C
8C1
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9-
K9.
KB0
M0R
M0S
M0T
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1038/s41541-024-00983-0
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & allied health premium.
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
Health & Medical Collection (Alumni Edition)
Healthcare Administration Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Public Health
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Health Management
Coronavirus Research Database
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

PubMed

MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7RV
  name: Nursing & allied health premium.
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 2059-0105
EndPage 2
ExternalDocumentID oai_doaj_org_article_5fb58b39a96942488d07810f1a3edd8c
PMC11519655
39468063
10_1038_s41541_024_00983_0
Genre Letter
Correspondence
GrantInformation_xml – fundername: U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI)
  grantid: T32 EY024236
  funderid: https://doi.org/10.13039/100000053
– fundername: Research to Prevent Blindness (RPB)
  grantid: P30EY025585
  funderid: https://doi.org/10.13039/100001818
– fundername: Research to Prevent Blindness (RPB)
  grantid: P30EY025585
– fundername: NEI NIH HHS
  grantid: T32 EY024236
GroupedDBID 0R~
53G
5VS
7RV
7X7
8C1
8FI
8FJ
AAJSJ
ABUWG
ACGFS
ACSMW
ADBBV
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BCNDV
BENPR
C6C
CCPQU
EBLON
EBS
ECGQY
FYUFA
GROUPED_DOAJ
HMCUK
HYE
K9-
KQ8
M0R
M0T
M~E
NAO
NAPCQ
OK1
PGMZT
PIMPY
RNT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFFHD
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
NPM
3V.
7XB
8FK
COVID
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c492t-eb33dad80907bd7e6f3b56e4930afa8c9ccdf0a876e73f00e7edcf0057043e963
IEDL.DBID DOA
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001345458800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2059-0105
IngestDate Fri Oct 03 12:52:34 EDT 2025
Tue Nov 04 02:06:04 EST 2025
Wed Oct 01 15:01:05 EDT 2025
Tue Oct 07 07:28:02 EDT 2025
Thu Apr 03 07:07:46 EDT 2025
Sat Nov 29 06:30:54 EST 2025
Fri Feb 21 02:37:00 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c492t-eb33dad80907bd7e6f3b56e4930afa8c9ccdf0a876e73f00e7edcf0057043e963
Notes SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/5fb58b39a96942488d07810f1a3edd8c
PMID 39468063
PQID 3121467030
PQPubID 4669711
PageCount 2
ParticipantIDs doaj_primary_oai_doaj_org_article_5fb58b39a96942488d07810f1a3edd8c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11519655
proquest_miscellaneous_3121593229
proquest_journals_3121467030
pubmed_primary_39468063
crossref_primary_10_1038_s41541_024_00983_0
springer_journals_10_1038_s41541_024_00983_0
PublicationCentury 2000
PublicationDate 2024-10-28
PublicationDateYYYYMMDD 2024-10-28
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-28
  day: 28
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle npj vaccines
PublicationTitleAbbrev npj Vaccines
PublicationTitleAlternate NPJ Vaccines
PublicationYear 2024
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Li (CR2) 2023; 8
CR6
Vujosevic (CR3) 2022; 1
Menter (CR7) 2020; 77
Cheng, Margo (CR4) 2022; 67
Dorney, Shaia, Kaelber, Talcott, Singh (CR1) 2023; 141
Jampol, Maguire (CR5) 2023; 141
983_CR6
S Vujosevic (983_CR3) 2022; 1
T Menter (983_CR7) 2020; 77
JX Li (983_CR2) 2023; 8
LM Jampol (983_CR5) 2023; 141
JY Cheng (983_CR4) 2022; 67
I Dorney (983_CR1) 2023; 141
References_xml – volume: 77
  start-page: 198
  year: 2020
  end-page: 209
  ident: CR7
  article-title: Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
  publication-title: Histopathology
  doi: 10.1111/his.14134
– volume: 8
  year: 2023
  ident: CR2
  article-title: Risk assessment of retinal vascular occlusion after COVID-19 vaccination
  publication-title: NPJ Vaccines
  doi: 10.1038/s41541-023-00661-7
– ident: CR6
– volume: 1
  start-page: 3
  year: 2022
  ident: CR3
  article-title: Retinal vascular occlusion and SARS-CoV-2 vaccination
  publication-title: Graefe’s Arch. Clin. Exp. Ophthalmol.
– volume: 141
  start-page: 447
  year: 2023
  end-page: 448
  ident: CR5
  article-title: No red flags for risk of retinal vascular occlusion after mRNA COVID-19 vaccination
  publication-title: JAMA Ophthalmol.
  doi: 10.1001/jamaophthalmol.2023.0925
– volume: 67
  start-page: 293
  year: 2022
  end-page: 306
  ident: CR4
  article-title: Ocular adverse events following vaccination: overview and update
  publication-title: Surv. Ophthalmol.
  doi: 10.1016/j.survophthal.2021.04.001
– volume: 141
  start-page: 441
  year: 2023
  end-page: 447
  ident: CR1
  article-title: Risk of new retinal vascular occlusion after mRNA COVID-19 vaccination within aggregated electronic health record data
  publication-title: JAMA Ophthalmol.
  doi: 10.1001/jamaophthalmol.2023.0610
– volume: 141
  start-page: 447
  year: 2023
  ident: 983_CR5
  publication-title: JAMA Ophthalmol.
  doi: 10.1001/jamaophthalmol.2023.0925
– volume: 1
  start-page: 3
  year: 2022
  ident: 983_CR3
  publication-title: Graefe’s Arch. Clin. Exp. Ophthalmol.
– volume: 141
  start-page: 441
  year: 2023
  ident: 983_CR1
  publication-title: JAMA Ophthalmol.
  doi: 10.1001/jamaophthalmol.2023.0610
– volume: 8
  year: 2023
  ident: 983_CR2
  publication-title: NPJ Vaccines
  doi: 10.1038/s41541-023-00661-7
– volume: 67
  start-page: 293
  year: 2022
  ident: 983_CR4
  publication-title: Surv. Ophthalmol.
  doi: 10.1016/j.survophthal.2021.04.001
– ident: 983_CR6
– volume: 77
  start-page: 198
  year: 2020
  ident: 983_CR7
  publication-title: Histopathology
  doi: 10.1111/his.14134
SSID ssj0001763570
Score 2.2793171
Snippet Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an...
Abstract Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 202
SubjectTerms 692/699/3161/3175
692/700/478
Biomedical and Life Sciences
Biomedicine
COVID-19
Infectious Diseases
Matters Arising
Medical Microbiology
Public Health
Vaccine
Virology
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagcODC-xEoyEioF9aqEzuJfUKlUMFlu6pKtTfLz7JCZMtmW7T_nrGT3bC8LhyTWJHtb2Y8nrG_QeiV9i4PUgSiec0Jl4CFpIwTaaR3lZeWa5OKTdTjsZhO5aQPuLX9scq1TUyG2s1tjJHvszyWoI7y-ebiG4lVo2J2tS-hcR3diGWzo5zX03qIsSS2NdrflaFM7LewXnHYPxecRCZNRujWepRo-__ka_5-ZPKXvGlajo7u_O9A7qLbvSOKDzrJuYeu-eY-2pt0TNarET4dLma1I7yHJwPH9eoBmn09GR_gw-Ozj-9ILvGVtnbWxRVbrBceN_Ml1j3y3uEY7cUnZ8fYDWeUcJFjp1fQvnE4L_B377_AQ6xZ_vP_HqJPR-9PDz-QvmoDsVwWSwK7c-a0ExS23cbVvgrMlJXnklEdtLDSWheoBivsaxYo9TXMaoiXYilnHuzBI7TTzBv_BGETvAR741glGLfcwNawpLr2puZlbiqaoddr7NRFR86hUlKdCdUhrQBplZBW0PpthHfTMhJrpxfzxbnq9VSVwZTCMKllJXkB1s1FNiQacs28c8JmaHeNquq1vVUDpBl6ufkMehqTL7rx88uuTQnOciEz9LiTpU1PmOSVAF8xQ2JLyra6uv2lmX1OXODg0EdOyDJDo7VADv36-1w8_fcwnqFbRdQRWKMLsYt2lotL_xzdtFfLWbt4kZTsB-9bLhU
  priority: 102
  providerName: ProQuest
Title mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination
URI https://link.springer.com/article/10.1038/s41541-024-00983-0
https://www.ncbi.nlm.nih.gov/pubmed/39468063
https://www.proquest.com/docview/3121467030
https://www.proquest.com/docview/3121593229
https://pubmed.ncbi.nlm.nih.gov/PMC11519655
https://doaj.org/article/5fb58b39a96942488d07810f1a3edd8c
Volume 9
WOSCitedRecordID wos001345458800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: DOA
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: M~E
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Consumer Health Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: M0R
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/familyhealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: 7X7
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Healthcare Administration Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: M0T
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthmanagement
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & allied health premium.
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: 7RV
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: BENPR
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: 8C1
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: PIMPY
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5B4cCl4o2hRIuEeiFW1961vXtsQyt6aGpFIQona58iQjhVnBbl3zO7dl48xIXLSM6uotE8dmb28Q1C76U1iRPcxZIVLGYCdCEIZbFQwprcCs2kCs0miuGQT6ei3Gn15e-EtfDAreBOMqcyrqiQIhcsBXMzHp6GuERSawzXfvUlhdgppsLuSsBZI90rGUL5SQORikHlnLLYY2jSmOxFogDY_6cs8_fLkr-cmIZAdPEYHXYZJD5tOX-C7tn6KTouWwjqVR-Pty-qmj4-xuUWnHr1DM2-j4aneHA9ufwYJwLfSa1n7YZgg-XC4nq-xLJTmTXYb9Pi0eQam-3lIpwm2MgVzK8NTlL8w9pv8OGbje_-33P0-eJ8PPgUd-0WYs1EuoyhrKZGGk6gXlamsLmjKsstE5RIJ7kWWhtHJCyftqCOEFuAUJx_zUoYteDIL9BBPa_tK4SVswIWCkNzTplmCmq6jMjCqoJlicpJhD6sRV_dtKgaVTgNp7xqFVWBoqqgqApmn3ntbGZ6ROzwA9hJ1dlJ9S87idDRWrdV56ZNRRPf19wvehF6txkGB_OnJrK289t2TgZZbioi9LI1hQ0nVLCcQ5IXIb5nJHus7o_Us68BxBsycQ_mmEWov7anLV9_l8Xr_yGLN-hR6h0BQnDKj9DBcnFr36KH-m45axY9dL8YTTydFoFyoHyQ9NCDs_NhOeoFTwN6RUaBjmGkvLwqv_wEwpQo5w
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLRJceD8CBYwEvbBRndhJ7ANCpaXqqu12VS1VORnHdmCFSMpm22r_FL8RO48Ny-vWA8ckluXY34xnxuNvAF5Io4OMs8yXNKE-5XYtOCbU5yk3OjZcUZlWxSaS4ZCdnPDRCnxv78K4tMpWJ1aKWhfKxcg3SOBKUDt8vjn95ruqUe50tS2hUcNiz8wvrMtWvh5s2_V9GYY778Zbu35TVcBXlIcz33qPREvNsHULU52YOCNpFBvKCZaZZIorpTMsrZYwCckwNonRKnOXNjElxuLV9nsFVqkDew9WR4OD0YcuqlPxu-Hmdg4mbKO0OyS1HntIfcfdSXy8tANWhQL-ZN3-nqT5y0lttQHu3Pzfpu4W3GhMbbRZy8ZtWDH5HVgf1Vzd8z4ad1fPyj5aR6OOxXt-FyZfj4abaOvweLDtBxydS6UmdeS0RHJqUF7MkGywbTRy8Wx0dHyIdJeFhcIAaTm37XONghBdGPPFPriq7D_3dw_eX8o03IdeXuTmIaA0M9xqVE1iRqiiqXV-IywTkyY0CtIYe_CqxYo4relHRJU2QJiokSUsskSFLGFbv3VwWrR01OHVi2L6STSaSERZGrGUcMljTkOrv7Xje8JZIInRmikP1loUiUaflaKDkAfPF5-tJnLHSzI3xVndJrLuQMg9eFBjdzESwmnMrDXsAVtC9dJQl7_kk88V27l1WRzrZeRBvxWAblx_n4tH__6NZ3Btd3ywL_YHw73HcD108mktkpCtQW82PTNP4Ko6n03K6dNGxBF8vGzR-AFlEY6n
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=mRNA+COVID-19+vaccinations+are+not+associated+with+RVO+development+21+days+and+12+weeks+after+vaccination&rft.jtitle=npj+vaccines&rft.au=Jacqueline+K.+Shaia&rft.au=Priya+Shukla&rft.au=Lee+Jampol&rft.au=Rishi+P.+Singh&rft.date=2024-10-28&rft.pub=Nature+Portfolio&rft.eissn=2059-0105&rft.volume=9&rft.issue=1&rft.spage=1&rft.epage=2&rft_id=info:doi/10.1038%2Fs41541-024-00983-0&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_5fb58b39a96942488d07810f1a3edd8c
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2059-0105&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2059-0105&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2059-0105&client=summon